エピレプシーにおける免疫媒介の炎症性疾患:自己免疫性の役割
Araceli Reyes-Cuayahuitl1, Diana Araceli Estrada-Garcia1, Nayeli Orea-Méndez1
1Servicio de Neurología Pediátrica, Hospital de Pediatría, "Dr. Silvestre Frenk Freund", Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico.
Epilepsy & behavior : E&B
|August 30, 2025
まとめ
発作の原因として,特に起源が不明な症例では,自己免疫プロセスがますます認識されています. 自己免疫性の早期診断と標的型免疫療法は,標準的な抗薬を超える効果的な治療に不可欠です.
科学分野:
- 神経免疫学
- エピレプト学
- 自己免疫 疾患
背景:
- 神経炎症は,自己免疫性脳炎症とラズミュッセン症候群の主要な例として,と関連しています.
- 自己免疫メカニズムは現在,発作の原因として認められており,発作原因不明の焦点性の推定5%に寄与している.
- 国際抗連盟は 自免疫病理学を 最新の発作病因分類に含んでいます
研究 の 目的:
- 自己免疫関連性の最近の進歩をレビューする.
- この疾患の病理生理学,診断,そして新興治療法について議論します.
主な方法:
- 自己免疫性に関する最新の文献のレビュー.
- 自己免疫性と関連した一般的な自己抗体 (GAD65,LGI1,GABAb受容体) の分析.
- 複数の自己抗体の同時発生を含む診断上の課題の検討
主要な成果:
- 自己免疫性脳炎は頻繁に発作を起こし,しばしば自己免疫性と混同される.
- 薬剤耐性性は複数の自己抗体を含み,診断と治療を複雑にします.
- 従来の抗発作薬が不十分である場合,免疫調節療法が有望である.
結論:
- 自己免疫性の管理には,自己抗体の早期発見と包括的な臨床評価が不可欠である.
- 新興の免疫療法が 免疫媒介による発作の患者に新しい希望をもたらしています
- 神経炎症の役割を理解することは 自己免疫性の治療を進めるための鍵です
さらに関連する動画
関連する概念動画
Autoimmune Disorders
667
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
667
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Antiepileptic Drugs: Glutamate Antagonists
511
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
511
Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
Antiepileptic Drugs: Calcium Channel Blockers
608
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
608


